- Home
- ABLV vs TURN Comparison
ABLV vs TURN Comparison
Compare ABLV & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- TURN
- Stock Information
- Founded
- ABLV 2015
- TURN 1981
- Country
- ABLV China
- TURN United States
- Employees
- ABLV N/A
- TURN N/A
- Industry
- ABLV
- TURN Finance/Investors Services
- Sector
- ABLV
- TURN Finance
- Exchange
- ABLV Nasdaq
- TURN Nasdaq
- Market Cap
- ABLV 38.1M
- TURN 35.4M
- IPO Year
- ABLV N/A
- TURN N/A
- Fundamental
- Price
- ABLV $1.10
- TURN $3.97
- Analyst Decision
- ABLV
- TURN
- Analyst Count
- ABLV 0
- TURN 0
- Target Price
- ABLV N/A
- TURN N/A
- AVG Volume (30 Days)
- ABLV 7.4K
- TURN 42.8K
- Earning Date
- ABLV 01-01-0001
- TURN 02-18-2025
- Dividend Yield
- ABLV N/A
- TURN N/A
- EPS Growth
- ABLV N/A
- TURN N/A
- EPS
- ABLV N/A
- TURN N/A
- Revenue
- ABLV $130,087,189.00
- TURN $129,297.00
- Revenue This Year
- ABLV N/A
- TURN N/A
- Revenue Next Year
- ABLV N/A
- TURN N/A
- P/E Ratio
- ABLV N/A
- TURN N/A
- Revenue Growth
- ABLV N/A
- TURN 6.32
- 52 Week Low
- ABLV $0.55
- TURN $3.12
- 52 Week High
- ABLV $3.10
- TURN $4.47
- Technical
- Relative Strength Index (RSI)
- ABLV 58.21
- TURN 59.72
- Support Level
- ABLV $1.02
- TURN $3.78
- Resistance Level
- ABLV $1.14
- TURN $4.04
- Average True Range (ATR)
- ABLV 0.06
- TURN 0.14
- MACD
- ABLV -0.01
- TURN 0.01
- Stochastic Oscillator
- ABLV 56.95
- TURN 73.91
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.